ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2026
Determination of Cardiac Troponin I in Guinea Pigs (Cavia porcellus) under Different Restraint Methods and Using a Point-of-Care Assay or Laboratory Analyzer.
Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guinea pigs are a commonly used model for laboratory research, as well as being housed in zoological institutions and kept as pets. These animals can develop cardiac disease, and additional diagnostic modalities are needed to help expediently and accurately diagnose it. Cardiac troponin I (cTnI) is a cardiac-specific biomarker associated with myocyte damage. The objectives of this study were to (1) determine the utility of a point-of-care (POC) cTnI assay in guinea pigs via cardiac and skeletal muscle tissue homogenates serially diluted in saline; (2) compare this POC assay to a high-sensitivity assay; and (3) determine the effect of restraint method (awake, isoflurane, and ketamine-xylazine) on cTnI measurements. A total of 45 guinea pigs were used in this study. Homogenates of cardiac muscle produced detectable concentrations of cTnI, while skeletal muscle homogenates did not. There was a significant difference between the POC (cTnI median 0.000 [range 0.000-0.0450] ng/mL) and the high-sensitivity (cTnI 0.025 [range 0.010-0.042] ng/mL) assays, suggesting that the former may require its own reference interval. There were no significant differences detected among the order of treatments (P = 0.66320), the method of restraint (P = 0.2315), or the interaction between the treatments (P = 0.9755); however, there were more nonzero values obtained for cTnI 7 days after anesthesia with ketamine-xylazine. These results suggest that this POC assay may be useful in the detection of cTnI in guinea pigs using a variety of restraint methods, although a high-sensitivity assay is recommended when low concentrations or small variations in concentration need to be detected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.